KS

Krishan Singh

Active Director Director DIN 11192950
DIN 11192950 First appointment Jul 2025 Primary industry Paper
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since Jul 2025
Shareholding value β€’β€’β€’β€’ Premium profile

About Krishan Singh

Data last updated:

Krishan Singh is a Director at Qerex Healthcare And Research Private Limited (since 2025). The company operates in Paper.

DIN 11192950
Primary Designation Director
Industry Paper
First Appointment 01 Jul 2025
Oldest Company Age 2 yrs

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director01 Jul 20252024Active

Directorship timeline

Open interactive timeline →
Qerex Healthcare And Research Private Limited
Premium access

Shareholding and investment profile for Krishan Singh

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Krishan Singh

Krishan Singh currently holds 1 directorship: Qerex Healthcare And Research Private Limited (Director, since 01 Jul 2025).

Krishan Singh was first appointed on 01 Jul 2025 as Director at Qerex Healthcare And Research Private Limited.

The current boards of Krishan Singh's companies include Anil Singh Thakur (Qerex Healthcare And Research Private Limited), Bindu Misra (Qerex Healthcare And Research Private Limited), Gopal Kumar Chauhan (Qerex Healthcare And Research Private Limited), Manish Kumar Srivastava (Qerex Healthcare And Research Private Limited), Vishvesh Kumar Shrivastawa (Qerex Healthcare And Research Private Limited).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available